|
|
Join the NPC team for a discussion with Neal Maskrey, Director of Evidence-Based Therapeutics and Andy Hutchinson, Education and Development Manager around three studies:
- Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease: the TIPS study (Lancet)
- Rosuvastatin venous thromboembolism, a secondary outcome in the JUPITER study (New England Journal of Medicine)
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis: the AURORA study (New England Journal of Medicine)
 |
Subscribe to the NPCi podcast via the iTunes store |
 |
Subscribe to the NPCi podcast via RSS feed |